Why the study?
Does transvenous atrial lead implantation improve outcomes and lead performance compared to epicardial implantation in Fontan patients?
Population
78 patients who had undergone Fontan surgery and required atrial pacing lead implantation between 1992 and…
Comparison
Transvenous atrial lead implantation vs Epicardial atrial lead implantation
Design
Cohort
Follow-up
Median 1.6 years (TV) and 3.6 years (Epi)
Authors
Loading...
Supports transvenous leads to minimize stay in Fontan patients; leaves open need for randomized confirmation of longevity.
Does transvenous atrial lead implantation improve outcomes and lead performance compared to epicardial implantation in Fontan patients?
Transvenous atrial pacing leads in Fontan patients offer lower procedural morbidity (shorter hospital stay) and equivalent lead performance and longevity compared to epicardial leads.
Takahashi et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: